| Literature DB >> 18798057 |
Laxmi Yeruva1, Keon J Pierre, Madhavi Bathina, Abiodun Elegbede, Stephen W Carper.
Abstract
Advanced prostate cancer cells are typically hormone independent, resistant to apoptosis and do not respond to chemotherapeutic agents. The ability of methyl jasmonate (MJ) and cis-jasmone (CJ) to inhibit growth in hormone independent prostate cancer cell lines, PC-3 and DU-145, was evaluated. CJ and MJ inhibited cell growth, induced cell cycle arrest and apoptosis. Detailed studies with the PC-3 cell line revealed that 2 mM CJ or MJ treatment resulted in caspase 3 activation and Tumor Necrosis Factor Receptor 1 (TNFR1) activation, all hallmarks of apoptosis. These phytochemicals could be useful in the management of advanced prostate cancer.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18798057 DOI: 10.1080/07357900801975272
Source DB: PubMed Journal: Cancer Invest ISSN: 0735-7907 Impact factor: 2.176